long intergenic non-protein coding RNA 1476Genealiases: []
Q-omics provides the consensus-scored LINC01476 profile across patient tissues and cancer cell-line models. LINC01476 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, LINC01476 is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, LINC01476 RNA expression shows 12,591 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight READ, KIRC, and GBM as cancer lineages where LINC01476 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01476 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01476 survival associations across molecular data types. LINC01476 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01476 RNA expression–survival associations across cancer types. High LINC01476 expression shows unfavorable associations in READ, BRCA, ACC, DLBC and PCPG, but favorable associations in OV. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for LINC01476 RNA expression.
This table summarizes LINC01476 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01476. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01476 shows higher tumor expression in KIRC. The KIRC box plot shows higher LINC01476 RNA expression in tumor versus normal tissue (log2 FC = +0.018, t-test p = .018).
This table shows molecular features associated with LINC01476 in patient tissues and cancer cell lines. In patient samples, LINC01476 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
